TrialJournal of clinical pharmacology2020

Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 Study.

Frédéric Vanhoutte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.